Delcath Systems, Inc. (NASDAQ:DCTH)’s share price traded up 9.1% during trading on Thursday . The company traded as high as $0.14 and last traded at $0.13. 98,717,002 shares changed hands during mid-day trading, a decline of 8% from the average session volume of 107,340,000 shares. The stock had previously closed at $0.12.

The company has a 50-day moving average price of $0.12 and a 200-day moving average price of $0.10. The firm’s market capitalization is $52.80 million.

A hedge fund recently raised its stake in Delcath Systems stock. Virtu KCG Holdings LLC raised its stake in Delcath Systems, Inc. (NASDAQ:DCTH) by 72.4% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,518,724 shares of the medical device company’s stock after acquiring an additional 637,689 shares during the period. Virtu KCG Holdings LLC owned about 1.28% of Delcath Systems worth $299,000 as of its most recent SEC filing. Institutional investors own 7.97% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Delcath Systems, Inc. (DCTH) Trading 9.1% Higher” was published by Daily Political and is the property of of Daily Political. If you are reading this piece on another website, it was illegally stolen and republished in violation of United States & international copyright & trademark legislation. The legal version of this piece can be accessed at https://www.dailypolitical.com/2017/09/09/delcath-systems-inc-dcth-trading-9-1-higher.html.

Delcath Systems Company Profile

Delcath Systems, Inc is a late-stage clinical development company with early commercial activity in Europe focused on cancers of the liver. The Company is a specialty pharmaceutical and medical device company developing its product, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.